Sponsor

Benaroya Research Institute

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Benaroya Research Institute appears in 17 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials17
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

17 shown
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1DNCT05281614 · lead sponsor · 2022-09-21
COMPLETED
Pre-operative Education Modalities to Decrease Opioid UseNCT04933084 · lead sponsor · 2021-09-16
UNKNOWN
Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1DNCT05847413 · lead sponsor · 2020-05-30
COMPLETED
Use of Pedometer Following Radical ProstatectomyNCT04206280 · lead sponsor · 2020-02-10
UNKNOWN
Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic ProstatectomyNCT04098809 · lead sponsor · 2017-11-09
COMPLETED
Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And SatisfactionNCT03950180 · lead sponsor · 2013-07-12
COMPLETED
Intraoperative Radiation Therapy in Early Stage Breast CancerNCT02266602 · lead sponsor · 2012-02-01
COMPLETED
Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate CancerNCT00577356 · lead sponsor · 2008-02-01
TERMINATED
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate CancerNCT00349557 · lead sponsor · 2006-04-01
COMPLETED
Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerNCT00242918 · lead sponsor · 2003-05-01
COMPLETED
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM MetricsNCT06401577 · collaborator · 2024-10-16
RECRUITING
Diabetes RElated to Acute Pancreatitis and Its MechanismsNCT05197920 · collaborator · 2022-01-14
RECRUITING
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)NCT03369821 · collaborator · 2017-09-19
RECRUITING
Genetics Of Autoimmunity In Type I DiabetesNCT03648918 · collaborator · 2001-08-01
RECRUITING
Development of Predictive BiomarkersNCT03423862 · collaborator · 2017-10-01
COMPLETED
Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRCNCT03428295 · collaborator · 2017-06-22
SUSPENDED
Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of AsthmaNCT00980707 · collaborator · 2009-08-01
COMPLETED

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Benaroya Research Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
docetaxel2
etanercept1
vedolizumab1
verapamil1

Sponsor roles

lead sponsor10
collaborator7
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.